nodes	percent_of_prediction	percent_of_DWPC	metapath
Zuclopenthixol—Glucose tolerance impaired—Furosemide—dilated cardiomyopathy	0.0267	0.0408	CcSEcCtD
Zuclopenthixol—Menstruation irregular—Spironolactone—dilated cardiomyopathy	0.0239	0.0364	CcSEcCtD
Zuclopenthixol—Breast enlargement—Spironolactone—dilated cardiomyopathy	0.0204	0.0311	CcSEcCtD
Zuclopenthixol—Moricizine—SCN5A—dilated cardiomyopathy	0.0163	0.603	CrCbGaD
Zuclopenthixol—Amenorrhoea—Spironolactone—dilated cardiomyopathy	0.0151	0.023	CcSEcCtD
Zuclopenthixol—Gynaecomastia—Spironolactone—dilated cardiomyopathy	0.0118	0.0181	CcSEcCtD
Zuclopenthixol—Apathy—Furosemide—dilated cardiomyopathy	0.0101	0.0154	CcSEcCtD
Zuclopenthixol—Flat affect—Furosemide—dilated cardiomyopathy	0.00999	0.0152	CcSEcCtD
Zuclopenthixol—Trifluoperazine—TNNC1—dilated cardiomyopathy	0.00915	0.338	CrCbGaD
Zuclopenthixol—Ataxia—Spironolactone—dilated cardiomyopathy	0.00903	0.0138	CcSEcCtD
Zuclopenthixol—Glycosuria—Furosemide—dilated cardiomyopathy	0.00888	0.0136	CcSEcCtD
Zuclopenthixol—Disturbance in attention—Furosemide—dilated cardiomyopathy	0.00831	0.0127	CcSEcCtD
Zuclopenthixol—Eosinophilia—Spironolactone—dilated cardiomyopathy	0.00822	0.0125	CcSEcCtD
Zuclopenthixol—Erectile dysfunction—Spironolactone—dilated cardiomyopathy	0.00764	0.0117	CcSEcCtD
Zuclopenthixol—Hyperlipidaemia—Lisinopril—dilated cardiomyopathy	0.00749	0.0114	CcSEcCtD
Zuclopenthixol—Drowsiness—Spironolactone—dilated cardiomyopathy	0.0074	0.0113	CcSEcCtD
Zuclopenthixol—Ventricular fibrillation—Lisinopril—dilated cardiomyopathy	0.00705	0.0108	CcSEcCtD
Zuclopenthixol—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.00691	0.0105	CcSEcCtD
Zuclopenthixol—Rhinorrhoea—Lisinopril—dilated cardiomyopathy	0.00667	0.0102	CcSEcCtD
Zuclopenthixol—Endocrine disorder—Lisinopril—dilated cardiomyopathy	0.00651	0.00994	CcSEcCtD
Zuclopenthixol—Urine output increased—Furosemide—dilated cardiomyopathy	0.00651	0.00993	CcSEcCtD
Zuclopenthixol—Polyuria—Furosemide—dilated cardiomyopathy	0.00595	0.00908	CcSEcCtD
Zuclopenthixol—Vascular purpura—Furosemide—dilated cardiomyopathy	0.00584	0.00891	CcSEcCtD
Zuclopenthixol—Haemolytic anaemia—Furosemide—dilated cardiomyopathy	0.00579	0.00883	CcSEcCtD
Zuclopenthixol—Thirst—Furosemide—dilated cardiomyopathy	0.00549	0.00837	CcSEcCtD
Zuclopenthixol—Purpura—Furosemide—dilated cardiomyopathy	0.00542	0.00827	CcSEcCtD
Zuclopenthixol—Ventricular tachycardia—Lisinopril—dilated cardiomyopathy	0.0054	0.00824	CcSEcCtD
Zuclopenthixol—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.00537	0.00819	CcSEcCtD
Zuclopenthixol—Salivary hypersecretion—Lisinopril—dilated cardiomyopathy	0.00524	0.008	CcSEcCtD
Zuclopenthixol—Malaise—Spironolactone—dilated cardiomyopathy	0.00522	0.00796	CcSEcCtD
Zuclopenthixol—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00518	0.0079	CcSEcCtD
Zuclopenthixol—Urinary retention—Furosemide—dilated cardiomyopathy	0.00497	0.00758	CcSEcCtD
Zuclopenthixol—Discomfort—Spironolactone—dilated cardiomyopathy	0.00486	0.00742	CcSEcCtD
Zuclopenthixol—Hypertonia—Lisinopril—dilated cardiomyopathy	0.00473	0.00722	CcSEcCtD
Zuclopenthixol—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00472	0.0072	CcSEcCtD
Zuclopenthixol—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00462	0.00705	CcSEcCtD
Zuclopenthixol—Eosinophilia—Furosemide—dilated cardiomyopathy	0.00447	0.00682	CcSEcCtD
Zuclopenthixol—Haemolytic anaemia—Lisinopril—dilated cardiomyopathy	0.00434	0.00662	CcSEcCtD
Zuclopenthixol—Nasal congestion—Lisinopril—dilated cardiomyopathy	0.0043	0.00656	CcSEcCtD
Zuclopenthixol—Libido decreased—Lisinopril—dilated cardiomyopathy	0.00423	0.00645	CcSEcCtD
Zuclopenthixol—Somnolence—Spironolactone—dilated cardiomyopathy	0.0042	0.0064	CcSEcCtD
Zuclopenthixol—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.00412	0.00629	CcSEcCtD
Zuclopenthixol—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00407	0.00622	CcSEcCtD
Zuclopenthixol—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.00407	0.00621	CcSEcCtD
Zuclopenthixol—Drowsiness—Furosemide—dilated cardiomyopathy	0.00403	0.00614	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00389	0.00593	CcSEcCtD
Zuclopenthixol—Disturbance in sexual arousal—Lisinopril—dilated cardiomyopathy	0.00389	0.00593	CcSEcCtD
Zuclopenthixol—Sweating—Furosemide—dilated cardiomyopathy	0.00386	0.00589	CcSEcCtD
Zuclopenthixol—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.00381	0.00581	CcSEcCtD
Zuclopenthixol—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.00376	0.00573	CcSEcCtD
Zuclopenthixol—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00373	0.00569	CcSEcCtD
Zuclopenthixol—Ataxia—Lisinopril—dilated cardiomyopathy	0.00369	0.00562	CcSEcCtD
Zuclopenthixol—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.00357	0.00544	CcSEcCtD
Zuclopenthixol—Urethral disorder—Furosemide—dilated cardiomyopathy	0.00354	0.0054	CcSEcCtD
Zuclopenthixol—Breast disorder—Lisinopril—dilated cardiomyopathy	0.00354	0.0054	CcSEcCtD
Zuclopenthixol—Nasopharyngitis—Lisinopril—dilated cardiomyopathy	0.00351	0.00535	CcSEcCtD
Zuclopenthixol—Visual impairment—Furosemide—dilated cardiomyopathy	0.00348	0.00531	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00348	0.0053	CcSEcCtD
Zuclopenthixol—Eye disorder—Furosemide—dilated cardiomyopathy	0.00338	0.00515	CcSEcCtD
Zuclopenthixol—Tinnitus—Furosemide—dilated cardiomyopathy	0.00337	0.00514	CcSEcCtD
Zuclopenthixol—Eosinophilia—Lisinopril—dilated cardiomyopathy	0.00335	0.00512	CcSEcCtD
Zuclopenthixol—Pruritus—Spironolactone—dilated cardiomyopathy	0.00334	0.00509	CcSEcCtD
Zuclopenthixol—Sweating increased—Lisinopril—dilated cardiomyopathy	0.0033	0.00503	CcSEcCtD
Zuclopenthixol—Angiopathy—Furosemide—dilated cardiomyopathy	0.00328	0.005	CcSEcCtD
Zuclopenthixol—Immune system disorder—Furosemide—dilated cardiomyopathy	0.00326	0.00498	CcSEcCtD
Zuclopenthixol—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00323	0.00493	CcSEcCtD
Zuclopenthixol—Arrhythmia—Furosemide—dilated cardiomyopathy	0.00323	0.00493	CcSEcCtD
Zuclopenthixol—Pancytopenia—Lisinopril—dilated cardiomyopathy	0.00322	0.00491	CcSEcCtD
Zuclopenthixol—Dysuria—Lisinopril—dilated cardiomyopathy	0.00317	0.00483	CcSEcCtD
Zuclopenthixol—Neutropenia—Lisinopril—dilated cardiomyopathy	0.00317	0.00483	CcSEcCtD
Zuclopenthixol—Erythema—Furosemide—dilated cardiomyopathy	0.00315	0.0048	CcSEcCtD
Zuclopenthixol—Malnutrition—Furosemide—dilated cardiomyopathy	0.00315	0.0048	CcSEcCtD
Zuclopenthixol—Dizziness—Spironolactone—dilated cardiomyopathy	0.00312	0.00476	CcSEcCtD
Zuclopenthixol—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.00312	0.00476	CcSEcCtD
Zuclopenthixol—Flatulence—Furosemide—dilated cardiomyopathy	0.0031	0.00473	CcSEcCtD
Zuclopenthixol—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	0.00309	0.00472	CcSEcCtD
Zuclopenthixol—Weight increased—Lisinopril—dilated cardiomyopathy	0.00308	0.0047	CcSEcCtD
Zuclopenthixol—Weight decreased—Lisinopril—dilated cardiomyopathy	0.00307	0.00468	CcSEcCtD
Zuclopenthixol—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.00306	0.00466	CcSEcCtD
Zuclopenthixol—Vomiting—Spironolactone—dilated cardiomyopathy	0.003	0.00458	CcSEcCtD
Zuclopenthixol—Rash—Spironolactone—dilated cardiomyopathy	0.00298	0.00454	CcSEcCtD
Zuclopenthixol—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00297	0.00454	CcSEcCtD
Zuclopenthixol—Vision blurred—Furosemide—dilated cardiomyopathy	0.00297	0.00452	CcSEcCtD
Zuclopenthixol—Headache—Spironolactone—dilated cardiomyopathy	0.00296	0.00451	CcSEcCtD
Zuclopenthixol—Jaundice—Lisinopril—dilated cardiomyopathy	0.00294	0.00449	CcSEcCtD
Zuclopenthixol—Sweating—Lisinopril—dilated cardiomyopathy	0.0029	0.00442	CcSEcCtD
Zuclopenthixol—Agitation—Furosemide—dilated cardiomyopathy	0.00289	0.00441	CcSEcCtD
Zuclopenthixol—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	0.00286	0.00436	CcSEcCtD
Zuclopenthixol—Vertigo—Furosemide—dilated cardiomyopathy	0.00283	0.00431	CcSEcCtD
Zuclopenthixol—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.00282	0.0043	CcSEcCtD
Zuclopenthixol—Leukopenia—Furosemide—dilated cardiomyopathy	0.00282	0.0043	CcSEcCtD
Zuclopenthixol—Nausea—Spironolactone—dilated cardiomyopathy	0.0028	0.00428	CcSEcCtD
Zuclopenthixol—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.00268	0.00409	CcSEcCtD
Zuclopenthixol—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.00267	0.00408	CcSEcCtD
Zuclopenthixol—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.00266	0.00406	CcSEcCtD
Zuclopenthixol—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.00266	0.00406	CcSEcCtD
Zuclopenthixol—Dry mouth—Furosemide—dilated cardiomyopathy	0.00262	0.004	CcSEcCtD
Zuclopenthixol—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.00257	0.00392	CcSEcCtD
Zuclopenthixol—Tinnitus—Lisinopril—dilated cardiomyopathy	0.00253	0.00386	CcSEcCtD
Zuclopenthixol—Shock—Furosemide—dilated cardiomyopathy	0.00253	0.00385	CcSEcCtD
Zuclopenthixol—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.00252	0.00384	CcSEcCtD
Zuclopenthixol—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.00251	0.00384	CcSEcCtD
Zuclopenthixol—Skin disorder—Furosemide—dilated cardiomyopathy	0.00249	0.0038	CcSEcCtD
Zuclopenthixol—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.00248	0.00379	CcSEcCtD
Zuclopenthixol—Angiopathy—Lisinopril—dilated cardiomyopathy	0.00246	0.00375	CcSEcCtD
Zuclopenthixol—Anorexia—Furosemide—dilated cardiomyopathy	0.00245	0.00373	CcSEcCtD
Zuclopenthixol—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.00242	0.0037	CcSEcCtD
Zuclopenthixol—Hypotension—Furosemide—dilated cardiomyopathy	0.0024	0.00366	CcSEcCtD
Zuclopenthixol—Mental disorder—Lisinopril—dilated cardiomyopathy	0.00238	0.00362	CcSEcCtD
Zuclopenthixol—Malnutrition—Lisinopril—dilated cardiomyopathy	0.00236	0.0036	CcSEcCtD
Zuclopenthixol—Erythema—Lisinopril—dilated cardiomyopathy	0.00236	0.0036	CcSEcCtD
Zuclopenthixol—Flatulence—Lisinopril—dilated cardiomyopathy	0.00233	0.00355	CcSEcCtD
Zuclopenthixol—Tension—Lisinopril—dilated cardiomyopathy	0.00232	0.00353	CcSEcCtD
Zuclopenthixol—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00231	0.00352	CcSEcCtD
Zuclopenthixol—Nervousness—Lisinopril—dilated cardiomyopathy	0.00229	0.0035	CcSEcCtD
Zuclopenthixol—Somnolence—Furosemide—dilated cardiomyopathy	0.00228	0.00348	CcSEcCtD
Zuclopenthixol—Decreased appetite—Furosemide—dilated cardiomyopathy	0.00223	0.00341	CcSEcCtD
Zuclopenthixol—Vision blurred—Lisinopril—dilated cardiomyopathy	0.00222	0.00339	CcSEcCtD
Zuclopenthixol—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.00222	0.00338	CcSEcCtD
Zuclopenthixol—Fatigue—Furosemide—dilated cardiomyopathy	0.00221	0.00338	CcSEcCtD
Zuclopenthixol—Tremor—Lisinopril—dilated cardiomyopathy	0.00221	0.00337	CcSEcCtD
Zuclopenthixol—Pain—Furosemide—dilated cardiomyopathy	0.0022	0.00335	CcSEcCtD
Zuclopenthixol—Constipation—Furosemide—dilated cardiomyopathy	0.0022	0.00335	CcSEcCtD
Zuclopenthixol—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.00219	0.00334	CcSEcCtD
Zuclopenthixol—Malaise—Lisinopril—dilated cardiomyopathy	0.00213	0.00325	CcSEcCtD
Zuclopenthixol—Vertigo—Lisinopril—dilated cardiomyopathy	0.00212	0.00324	CcSEcCtD
Zuclopenthixol—Syncope—Lisinopril—dilated cardiomyopathy	0.00212	0.00323	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00212	0.00323	CcSEcCtD
Zuclopenthixol—Leukopenia—Lisinopril—dilated cardiomyopathy	0.00211	0.00322	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.0021	0.0032	CcSEcCtD
Zuclopenthixol—Palpitations—Lisinopril—dilated cardiomyopathy	0.00209	0.00318	CcSEcCtD
Zuclopenthixol—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.00207	0.00317	CcSEcCtD
Zuclopenthixol—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00203	0.0031	CcSEcCtD
Zuclopenthixol—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00203	0.0031	CcSEcCtD
Zuclopenthixol—Myalgia—Lisinopril—dilated cardiomyopathy	0.00201	0.00307	CcSEcCtD
Zuclopenthixol—Anxiety—Lisinopril—dilated cardiomyopathy	0.002	0.00306	CcSEcCtD
Zuclopenthixol—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.002	0.00304	CcSEcCtD
Zuclopenthixol—Discomfort—Lisinopril—dilated cardiomyopathy	0.00199	0.00303	CcSEcCtD
Zuclopenthixol—Dry mouth—Lisinopril—dilated cardiomyopathy	0.00197	0.003	CcSEcCtD
Zuclopenthixol—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.00193	0.00294	CcSEcCtD
Zuclopenthixol—Shock—Lisinopril—dilated cardiomyopathy	0.0019	0.00289	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00189	0.00289	CcSEcCtD
Zuclopenthixol—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.00189	0.00288	CcSEcCtD
Zuclopenthixol—Tachycardia—Lisinopril—dilated cardiomyopathy	0.00188	0.00287	CcSEcCtD
Zuclopenthixol—Skin disorder—Lisinopril—dilated cardiomyopathy	0.00187	0.00285	CcSEcCtD
Zuclopenthixol—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.00186	0.00284	CcSEcCtD
Zuclopenthixol—Asthenia—Furosemide—dilated cardiomyopathy	0.00184	0.00281	CcSEcCtD
Zuclopenthixol—Anorexia—Lisinopril—dilated cardiomyopathy	0.00184	0.0028	CcSEcCtD
Zuclopenthixol—Pruritus—Furosemide—dilated cardiomyopathy	0.00182	0.00277	CcSEcCtD
Zuclopenthixol—Hypotension—Lisinopril—dilated cardiomyopathy	0.0018	0.00275	CcSEcCtD
Zuclopenthixol—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00176	0.00268	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.00176	0.00268	CcSEcCtD
Zuclopenthixol—Insomnia—Lisinopril—dilated cardiomyopathy	0.00174	0.00266	CcSEcCtD
Zuclopenthixol—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.00173	0.00264	CcSEcCtD
Zuclopenthixol—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.00172	0.00262	CcSEcCtD
Zuclopenthixol—Somnolence—Lisinopril—dilated cardiomyopathy	0.00171	0.00261	CcSEcCtD
Zuclopenthixol—Dizziness—Furosemide—dilated cardiomyopathy	0.0017	0.00259	CcSEcCtD
Zuclopenthixol—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.0017	0.00259	CcSEcCtD
Zuclopenthixol—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.00167	0.00255	CcSEcCtD
Zuclopenthixol—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.00166	0.00254	CcSEcCtD
Zuclopenthixol—Fatigue—Lisinopril—dilated cardiomyopathy	0.00166	0.00253	CcSEcCtD
Zuclopenthixol—Constipation—Lisinopril—dilated cardiomyopathy	0.00165	0.00251	CcSEcCtD
Zuclopenthixol—Pain—Lisinopril—dilated cardiomyopathy	0.00165	0.00251	CcSEcCtD
Zuclopenthixol—Vomiting—Furosemide—dilated cardiomyopathy	0.00163	0.00249	CcSEcCtD
Zuclopenthixol—Loxapine—ADRB1—dilated cardiomyopathy	0.00162	0.0599	CrCbGaD
Zuclopenthixol—Rash—Furosemide—dilated cardiomyopathy	0.00162	0.00247	CcSEcCtD
Zuclopenthixol—Dermatitis—Furosemide—dilated cardiomyopathy	0.00162	0.00247	CcSEcCtD
Zuclopenthixol—Headache—Furosemide—dilated cardiomyopathy	0.00161	0.00245	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.00159	0.00242	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.00158	0.0024	CcSEcCtD
Zuclopenthixol—Nausea—Furosemide—dilated cardiomyopathy	0.00153	0.00233	CcSEcCtD
Zuclopenthixol—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.00152	0.00232	CcSEcCtD
Zuclopenthixol—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00152	0.00232	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00142	0.00217	CcSEcCtD
Zuclopenthixol—Asthenia—Lisinopril—dilated cardiomyopathy	0.00138	0.00211	CcSEcCtD
Zuclopenthixol—Pruritus—Lisinopril—dilated cardiomyopathy	0.00136	0.00208	CcSEcCtD
Zuclopenthixol—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00132	0.00201	CcSEcCtD
Zuclopenthixol—Dizziness—Lisinopril—dilated cardiomyopathy	0.00127	0.00194	CcSEcCtD
Zuclopenthixol—Vomiting—Lisinopril—dilated cardiomyopathy	0.00122	0.00187	CcSEcCtD
Zuclopenthixol—Rash—Lisinopril—dilated cardiomyopathy	0.00121	0.00185	CcSEcCtD
Zuclopenthixol—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00121	0.00185	CcSEcCtD
Zuclopenthixol—Headache—Lisinopril—dilated cardiomyopathy	0.00121	0.00184	CcSEcCtD
Zuclopenthixol—Nausea—Lisinopril—dilated cardiomyopathy	0.00114	0.00175	CcSEcCtD
Zuclopenthixol—HTR2A—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000286	0.000901	CbGpPWpGaD
Zuclopenthixol—HRH1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000285	0.000899	CbGpPWpGaD
Zuclopenthixol—DRD1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000285	0.000897	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000282	0.000887	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.00028	0.000883	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000278	0.000877	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000278	0.000876	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000278	0.000876	CbGpPWpGaD
Zuclopenthixol—DRD1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000276	0.000869	CbGpPWpGaD
Zuclopenthixol—HTR6—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000274	0.000862	CbGpPWpGaD
Zuclopenthixol—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.000268	0.000845	CbGpPWpGaD
Zuclopenthixol—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.000268	0.000843	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000267	0.000842	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.000263	0.000827	CbGpPWpGaD
Zuclopenthixol—DRD5—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000261	0.000823	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.00026	0.00082	CbGpPWpGaD
Zuclopenthixol—HTR6—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.00026	0.000818	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000259	0.000815	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.00025	0.000789	CbGpPWpGaD
Zuclopenthixol—DRD5—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000249	0.000786	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000248	0.000783	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000247	0.000779	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000247	0.000779	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	0.000239	0.000752	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000237	0.000747	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000236	0.000743	CbGpPWpGaD
Zuclopenthixol—DRD1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000235	0.000742	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000231	0.000729	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000231	0.000729	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—ANKRD1—dilated cardiomyopathy	0.000231	0.000728	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Hemostasis—ITGB1—dilated cardiomyopathy	0.000231	0.000727	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.00023	0.000724	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000228	0.000717	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000228	0.000717	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000227	0.000715	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000227	0.000715	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000226	0.000714	CbGpPWpGaD
Zuclopenthixol—HTR2A—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.000226	0.000713	CbGpPWpGaD
Zuclopenthixol—DRD1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000223	0.000704	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000223	0.000702	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000223	0.000702	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000223	0.000701	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000221	0.000698	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000218	0.000686	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000217	0.000685	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—TAZ—dilated cardiomyopathy	0.000217	0.000685	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000215	0.000677	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000215	0.000677	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000214	0.000674	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000213	0.000672	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000212	0.000666	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000211	0.000665	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.00021	0.000662	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.00021	0.000662	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000208	0.000656	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000207	0.000653	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000207	0.000652	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000207	0.000652	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000207	0.000651	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000207	0.000651	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000206	0.00065	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000206	0.00065	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000205	0.000645	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000204	0.000644	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000203	0.000639	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000202	0.000637	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000202	0.000637	CbGpPWpGaD
Zuclopenthixol—HTR6—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000201	0.000635	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000201	0.000632	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000198	0.000624	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Hemostasis—CD36—dilated cardiomyopathy	0.000197	0.00062	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—SDHA—dilated cardiomyopathy	0.000197	0.000619	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000195	0.000615	CbGpPWpGaD
Zuclopenthixol—HTR6—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000193	0.000607	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000192	0.000606	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000192	0.000605	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000192	0.000604	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000191	0.000601	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000191	0.000601	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.00019	0.000599	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000189	0.000596	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000188	0.000593	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000188	0.000592	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000188	0.000592	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000186	0.000587	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000186	0.000586	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000186	0.000585	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Hemostasis—RAC1—dilated cardiomyopathy	0.000185	0.000584	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000185	0.000583	CbGpPWpGaD
Zuclopenthixol—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.000184	0.000579	CbGpPWpGaD
Zuclopenthixol—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.000183	0.000578	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000183	0.000577	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000182	0.000574	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.00018	0.000568	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.00018	0.000567	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000178	0.00056	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000177	0.000559	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000175	0.000551	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000175	0.000551	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000175	0.000551	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000175	0.00055	CbGpPWpGaD
Zuclopenthixol—DRD1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000173	0.000547	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000172	0.000541	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000171	0.00054	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000169	0.000533	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000169	0.000531	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000166	0.000523	CbGpPWpGaD
Zuclopenthixol—DRD1—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000166	0.000522	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000166	0.000522	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000164	0.000518	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000164	0.000518	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000163	0.000512	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000161	0.000509	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000159	0.000502	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000159	0.000501	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000159	0.0005	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000157	0.000496	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000157	0.000495	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000156	0.00049	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000155	0.000488	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000153	0.000483	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000153	0.000481	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000151	0.000476	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000151	0.000475	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—AGT—dilated cardiomyopathy	0.00015	0.000474	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.00015	0.000474	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000148	0.000466	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000148	0.000465	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000147	0.000462	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000145	0.000455	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—RAC1—dilated cardiomyopathy	0.00014	0.000441	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.00014	0.00044	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000139	0.000439	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000137	0.000433	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000137	0.000432	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000137	0.000432	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000135	0.000424	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—AGT—dilated cardiomyopathy	0.000134	0.000422	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000131	0.000413	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000129	0.000406	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000129	0.000405	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000126	0.000398	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000126	0.000398	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000125	0.000394	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000125	0.000394	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000124	0.000391	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000124	0.000391	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000123	0.000388	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Hemostasis—RAF1—dilated cardiomyopathy	0.000123	0.000388	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000123	0.000387	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000122	0.000385	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000122	0.000385	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000122	0.000384	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000122	0.000384	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000121	0.000382	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000121	0.00038	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.00012	0.000378	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.00012	0.000377	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.00012	0.000377	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.00012	0.000377	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000119	0.000375	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000117	0.000369	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000117	0.000369	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000117	0.000368	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000115	0.000363	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000115	0.000361	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000114	0.000358	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000113	0.000358	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000113	0.000357	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000112	0.000353	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000112	0.000352	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000112	0.000352	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000112	0.000352	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000111	0.00035	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000111	0.00035	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000111	0.00035	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.00011	0.000346	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.00011	0.000346	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000109	0.000345	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000108	0.000341	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000108	0.00034	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000108	0.000339	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000106	0.000335	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000104	0.000329	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—AGT—dilated cardiomyopathy	0.000103	0.000325	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000103	0.000325	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000103	0.000324	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000102	0.00032	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.0001	0.000315	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—AGTR1—dilated cardiomyopathy	9.54e-05	0.000301	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—AGTR1—dilated cardiomyopathy	9.38e-05	0.000296	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—AGTR1—dilated cardiomyopathy	9.36e-05	0.000295	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—RAC1—dilated cardiomyopathy	9.3e-05	0.000293	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—RAF1—dilated cardiomyopathy	9.29e-05	0.000293	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—AGTR1—dilated cardiomyopathy	9.19e-05	0.00029	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—ADRB2—dilated cardiomyopathy	9.05e-05	0.000285	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—ADRB2—dilated cardiomyopathy	8.9e-05	0.000281	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—AGT—dilated cardiomyopathy	8.89e-05	0.00028	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—ADRB2—dilated cardiomyopathy	8.88e-05	0.00028	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—ADRB2—dilated cardiomyopathy	8.72e-05	0.000275	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—AGTR1—dilated cardiomyopathy	8.54e-05	0.000269	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling by GPCR—EGFR—dilated cardiomyopathy	8.32e-05	0.000262	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—GPX1—dilated cardiomyopathy	8.19e-05	0.000258	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—ADRB2—dilated cardiomyopathy	8.1e-05	0.000255	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—CD36—dilated cardiomyopathy	7.98e-05	0.000251	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—RAF1—dilated cardiomyopathy	7.88e-05	0.000248	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	7.78e-05	0.000245	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—RAF1—dilated cardiomyopathy	7.76e-05	0.000244	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—RAF1—dilated cardiomyopathy	7.74e-05	0.000244	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	7.65e-05	0.000241	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	7.63e-05	0.000241	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—RAF1—dilated cardiomyopathy	7.6e-05	0.000239	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	7.49e-05	0.000236	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—AGT—dilated cardiomyopathy	7.19e-05	0.000226	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—RAF1—dilated cardiomyopathy	7.17e-05	0.000226	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—EGFR—dilated cardiomyopathy	7.16e-05	0.000226	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—RAF1—dilated cardiomyopathy	7.06e-05	0.000222	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—RAC1—dilated cardiomyopathy	7.02e-05	0.000221	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	6.96e-05	0.000219	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—RAC1—dilated cardiomyopathy	6.91e-05	0.000218	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—RAC1—dilated cardiomyopathy	6.9e-05	0.000217	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—RAC1—dilated cardiomyopathy	6.77e-05	0.000213	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—AGT—dilated cardiomyopathy	6.71e-05	0.000211	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—AGT—dilated cardiomyopathy	6.6e-05	0.000208	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—AGT—dilated cardiomyopathy	6.59e-05	0.000208	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—AGT—dilated cardiomyopathy	6.47e-05	0.000204	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—EGFR—dilated cardiomyopathy	6.37e-05	0.000201	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—RAC1—dilated cardiomyopathy	6.29e-05	0.000198	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—RAF1—dilated cardiomyopathy	6.17e-05	0.000194	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—AGT—dilated cardiomyopathy	6.01e-05	0.000189	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—EGFR—dilated cardiomyopathy	5.41e-05	0.00017	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—GPX1—dilated cardiomyopathy	5.34e-05	0.000168	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—EGFR—dilated cardiomyopathy	5.32e-05	0.000168	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—EGFR—dilated cardiomyopathy	5.31e-05	0.000167	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—EGFR—dilated cardiomyopathy	5.21e-05	0.000164	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—CD36—dilated cardiomyopathy	5.2e-05	0.000164	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—EGFR—dilated cardiomyopathy	4.91e-05	0.000155	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—EGFR—dilated cardiomyopathy	4.84e-05	0.000153	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—AGT—dilated cardiomyopathy	4.68e-05	0.000148	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—RAF1—dilated cardiomyopathy	4.66e-05	0.000147	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—RAF1—dilated cardiomyopathy	4.58e-05	0.000144	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—RAF1—dilated cardiomyopathy	4.57e-05	0.000144	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—RAF1—dilated cardiomyopathy	4.49e-05	0.000141	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—EGFR—dilated cardiomyopathy	4.23e-05	0.000133	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—RAF1—dilated cardiomyopathy	4.17e-05	0.000131	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—EGFR—dilated cardiomyopathy	3.19e-05	0.000101	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—EGFR—dilated cardiomyopathy	3.14e-05	9.9e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—EGFR—dilated cardiomyopathy	3.14e-05	9.88e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—EGFR—dilated cardiomyopathy	3.08e-05	9.7e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—EGFR—dilated cardiomyopathy	2.86e-05	9.01e-05	CbGpPWpGaD
